Spiegel Boris Isaakovich

Spiegel Boris Isaakovich

Boris Spiegel was born on February 18, 1953 in the city of Khmelnitsky in Ukraine.

Education

In 1980 he graduated from the Faculty of History of Kamenetz-Podolsk State Pedagogical Institute. V.P. Zatonsky.

In 2003, Spiegel graduated from the All-Russian Academy of Foreign Trade. In 2005, he received a Ph.D. in Economics, defending his thesis on "Problems and Prospects for the Development of Energy Exports from Russia."

Biography

1990-1991

Until 1990, Spiegel worked at the All-Russian Research Institute of Agricultural Biotechnology, was the deputy director of this institution.

In 1991, he created and headed the pharmaceutical company Biotek.

2003

In 2003, Boris Spiegel became a senator from the executive branch of the Penza region and transferred the business to his wife. He served as First Deputy Chairman of the Federation Council Committee on Constitutional Legislation, Legal and Judicial Issues, the Development of Civil Society and the Head of the Federation Council Cooperation Group with the Knesset of Israel.

2021

Charge of giving bribes to the governor of the Penza region

March 22, 2021 Investigative Committee Russia presented official charges to the chairman of the board of directors of the group of companies "" Bioenergy industry Boris Spiegel in giving bribes to the governor of the Penza region. Ivan Belozertsev

According to the investigation, from January to September 2020, Belozertsev received bribes and valuables totaling 31 million rubles from Spiegel and his wife, as well as the director of Pharmacy, Anton Koloskov. This provided the Biotek group with advantages when concluding state contracts for the needs of hospitals and clinics in the region.

It is known that the money was transferred in Moscow both before and after Belozertsev's re-election for a second term. The governor and Spiegel face up to 15 years in prison. According to Druzhinina, Spiegel does not admit guilt.

According to Olga Druzhinina, a member of the Public Monitoring Commission (PMC), Boris Shpigel does not admit guilt in the alleged crime. While in the isolation ward on Petrovka, he became ill, the employees of the isolation ward called an ambulance.

He has very serious health problems, he has a number of diseases. Spiegel breathes with the help of a special device, which he has with him in the IVS. The employees of the isolation ward have already called him an ambulance and are ready to do it again at the first request of the detainee, - said Druzhinina.[1]

Spiegel told his version of the arrest

At the end of March 2021, the head of Biotek , Boris Shpigel, who was arrested on charges of giving bribes to the former governor of the Penza  region, Ivan Belozertsev, told his version of the high-profile case.

What happens to me is a clean order. I was hinted at sharing the business. I think nobody liked that my business was growing and revenue was growing. And they just decided to throw me out of the market. The investigator tells me: you will sit down anyway, you will still go to the zone. But I'm just afraid I'm going to die. Because this is the easiest option for them: I will rot here, and they will simply take my business, "Spiegel said in a conversation with human rights activist Marina Litvinovich, who asked him a few questions from Kommersant.

Boris Spiegel in the Basmanny District Court

According to him, nine months ago an operative came to his home, who was asked to accept a colonel of the FSB of Russia, familiar with the businessman.

This employee... offered me a "roof" and said that I needed to give a controlling stake in my business. After all, you know, the entire pharmaceutical business is now under certain security forces, and only Biotek was under no one. I was free, and here they decided to just take my business. I refused to share the business in that conversation and gave up the "roof," Spiegel said.

He called his condition "very serious," said that he was diagnosed with cancer and he practically cannot move independently.

Spiegel admitted that he gave the watch to Ivan Belozertsev in response to his "symbolic" gift for the New Year - a basket of fruits.

I became uncomfortable that I did not congratulate him, I had nothing prepared, and I, frankly, took a watch from my collection and sent him, - said the head of Biotek, adding that this is not a new watch and "not the most expensive" from his collection.[2]

2024

Sentence - 11 years of strict regime for bribes

On January 25, 2024, the Izmailovsky Court of Moscow sentenced Boris Shpigel, former chairman of the board of directors of the Biotek group of companies, to 11 years in prison with a sentence in a maximum security prison. He was found guilty of giving a particularly large bribe (part 5 of article 291 of the Criminal Code). The entrepreneur did not admit his guilt.

According to investigators, from June 2019 to September 2020, Ivan Belozertsev, who was then governor of the Penza region, received 30 million rubles in the form of money, property and services from Boris Shpigel and his wife Evgenia. In particular, the couple presented the ex-governor with a Breguet watch worth 5.7 million rubles for patronizing their pharmaceutical business. In particular, Belozertsev was supposed to provide the Biotek group of companies with the conclusion of state contracts with OJSC Pharmacy.

Boris Spiegel

As a result, the ex-governor of the Penza region in this case was sentenced to 12 years in prison. The former official will also serve his sentence in a maximum security colony. The head of the Pharmacy company, Anton Koloskov, was sentenced by the court to eight years and six months in a strict regime colony with a fine for giving a bribe. The court appointed Boris Spiegel's wife, Evgenia Spiegel, eight and a half years in a general regime colony on charges of giving a bribe.

At the debate, the state prosecutor asked to sentence Belozertsev to 13 years of strict regime, and Shpigel to 12, and to fine both in an amount 17 times the amount of the bribe imputed to him, Interfax reports citing lawyers of the accused. In addition to the prison term, the punishment against Boris Spiegel includes a fine of more than 450 million rubles.

According to experts interviewed by Izvestia, after the conviction against Boris Spiegel, Biotek may cease to exist, and its creditors will be left with nothing.^[3]

Recovery of 8.2 billion rubles in favor of the state

Convicted in the bribery case, the founder of the pharmaceutical group Bioenergy industry"" Boris Spiegel, the ex-governor Penza region Ivan Belozertsev and their accomplices are obliged to provide states 8.16 billion rubles in income. The corresponding decision at the end of January 2024 was made by the Oktyabrsky District Court of Penza.

This amount [8 158 102 085 rubles] was received by them as a result of violation of the prohibitions established by the anti-corruption legislation when concluding and executing state contracts for the supply of medicines and medical devices for the needs of healthcare institutions in the Penza region in the period from May 2015 to March 2021, the court said.

source = Komsomolskaya Pravda

In November 2023, the Prosecutor General's Office asked to recover from Belozertsev, Shpigel, his wife Evgenia, the general director of Pharmacy Anton Koloskov, companies of the Biotek group 9.9 billion rubles earned, according to the department, as a result of corruption crimes. Hearings on the lawsuit began on January 16, 2024 and took place behind closed doors due to the impossibility of transporting Spiegel to court due to his "large and detailed history of cardiological and other diseases," as the businessman's lawyers explained.

The prosecution insisted that in 2019-2020, Belozertsev personally and through intermediaries received a bribe from Spiegel, his wife and Koloskov in the form of money and expensive Swiss wristwatches. The total amount of the bribe was estimated at more than 30 million rubles. Another investigation claimed that Belozertsev was given a representative class car for free use. In exchange, the governor provided Pharmacy with competitive advantages when concluding state contracts for the supply of medicines and medicines in the region.^[4]

Notes